EpimAb Biotherapeutics
Developing a portfolio of novel bi-specific antibodies in oncology and immune-oncology. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€436—655m (Dealroom.co estimates Mar 2021.)
Shanghai Shanghai (HQ)
Authorizing premium user...